This hypothesis is further supported by the high prevalence of unrecognised heart failure in imaging and autopsy studies, [64] and the improved outcomes associated with angiotensin converting enzyme inhibitors and beta-blockers in observational COPD studies [65, 66]. This evidence concerns the gene ACE and heart failure.